INTRODUCTION
============

RNA interference (RNAi) is a powerful method for carrying out loss-of-function studies in diverse organisms and cell types ([@B19]; [@B41]; [@B51]; [@B56]). Its usefulness and reliability is exemplified by the fact that RNAi is frequently used for loss-of-function screening in organisms, like *C. elegans* ([@B20]; [@B1]; [@B29]; [@B30]; [@B37]; [@B47]; [@B52]; [@B58]) and *D. melanogaster* ([@B34]; [@B3]; [@B10]; [@B13]; [@B7]), that are also amenable to classical forward and reverse genetic approaches. Moreover, RNAi has allowed loss-of-function experiments and screens to be performed in vertebrate cells where alternative approaches are much more limited ([@B15]; [@B5]; [@B36]; [@B45]).

In vertebrate systems, RNAi is generally accomplished by the transfection or expression of small interfering RNAs (siRNAs), which avoids the non-specific suppression of protein synthesis induced by larger dsRNAs in many vertebrate cell types ([@B15]). The antisense strand of the siRNA guides RNA-induced silencing complexes (RISC) to complementary mRNAs via nucleic acid interactions ([@B21]; [@B16]) and subsequently the mRNAs are cleaved by an endonuclease ([@B61]; [@B40]; [@B55]) and digested to single nucleotides by an exonuclease ([@B6]).

Because base pairing is ordinarily very precise, the target specificity of siRNAs could be very high, and initial indications were that this was the case. In *C. elegans* RNAi phenotypes correlate well with true genetic null phenotypes for many genes ([@B19]). In mammalian cells, studies of luciferase reporter genes indicated high specificity of siRNAs for their intended targets as well; single base pair changes could abolish an siRNA\'s ability to silence its target ([@B15]).

Recently, microarray analysis has been used to look more comprehensively for siRNA off-target effects. One group showed that an exogenous green fluorescent protein gene could be silenced with only small variations in the levels of endogenous mRNAs (mostly \>2-fold) ([@B8]). Because these changes were inconsistent between replicates, they were attributed to experimental noise ([@B8]). A second group silenced several endogenous targets and analyzed global mRNA changes by microarray analysis ([@B50]). As long as the siRNA concentration was less than 20 nM, different siRNAs to the same target were found to produce similar mRNA changes ([@B50]). This argued that most of the changes in mRNA levels were secondary to the reduction of the intended target, rather than unwanted off-target effects ([@B50]).

However, a third group found that siRNAs could trigger off-target effects. Each of eight siRNAs designed to suppress p38α MAPK (also termed MAPK14) was found to also cause changes in the abundances of many other mRNAs ([@B25]). Each siRNA affected a different subset of mRNAs, implying that the changes were sequence-specific off-target effects rather than non-sequence-specific toxic effects or secondary effects of p38α MAPK suppression ([@B25]). Off-target effects could not be avoided by simply decreasing the dose of siRNA or confining the experiment to a particular time window ([@B25]). Similar results were found for a second target, IGF1R (insulin-like growth factor receptor) ([@B25]). These findings indicated that off-target effects might be fairly common in siRNA-treated cells. This conclusion was particularly worrisome in light of the exploding popularity of siRNA approaches for loss-of-function experiments and screens.

The prevailing hypothesis is that many of the off-target effects of siRNAs are mediated by cross-hybridization due to stretches of limited identity between the siRNAs and the off-target genes. This suggests a number of potential strategies for reducing cross-hybridization and off-target effects. Off-target effects resulting from the passenger siRNA strand can potentially be eliminated by modifications that prevent its incorporation into the RISC. For example, chemically modified siRNAs and locked nucleic acids have been used to prevent passenger siRNA strand mediated RNA cleavage ([@B17]; [@B27]).

Recent studies on the sequence requirements for RNAi-mediated gene silencing have suggested ways of decreasing off-target effects that are the result of cross-hybridization between a transcript and either the guide or passenger strand of the siRNA. Both the number and position of mismatches between the siRNA strands and a cross-hybridizing gene affects the likelihood of off-target silencing ([@B12]; [@B22]). In general, mismatches within the core of the sequence are more detrimental to silencing than mismatches at either the 5′- or 3′-end, although there are some disparities regarding the importance of the 5′-end ([@B12]; [@B22]).

Additional studies found that 6 or 7 consecutive matches between the siRNA guide strand and the off-target RNA as well as the context of the matching sequence within the off-target RNA are important parameters that determine whether or not an off-target mRNA is cleaved ([@B38]; [@B2]). In concert with *in silico* analyses of siRNA specificity ([@B24]; [@B49]) these empirical measures of specificity have resulted in siRNA design algorithms that avoid particular siRNA sequences that may decrease off-target transcript abundance.

In addition, there may be off-target effects that do not depend upon cross-hybridization between the siRNA and the off-target genes ([@B4]; [@B53]; [@B54]; [@B31]; [@B32]; [@B46]; [@B28]). These may include aptamer-like effects or other poorly understood sequence-specific, cross-hybridization-independent mechanisms.

We and others have shown that complex pools of siRNAs can be produced by incubating *in vitro* transcribed long double stranded RNAs (∼500 bp) with recombinant bacterial RNase III ([@B60]; [@B35]) or recombinant human Dicer ([@B48]; [@B62]; [@B33]; [@B44]). These pools compare favorably with chemically synthesized siRNAs in terms of their effectiveness ([@B44]; [@B42]; [@B43]), and they have been successfully applied to both large scale screens ([@B39]) and functional studies of individual proteins ([@B18]; [@B44]; [@B26]; [@B9]).

Here we address the issue of off-target changes in mRNA abundance for Dicer-generated siRNA pools (d-siRNAs) and RNase III-generated siRNA pools (e-siRNAs). *A priori*, it seemed possible that the pools might be more problematic than single siRNAs, since a typical diced pool contains many different siRNAs, each of which might contribute off-target effects. On the other hand, the low absolute concentration of any individual problematic siRNAs in a pool might render their off-target effects insignificant, particularly if each problematic siRNA affected a different subset of genes. To distinguish between these two possibilities, we have examined the complexity of diced siRNA pools, and compared the off-target effects of d-siRNAs and e-siRNAs to those of three chemically synthesized siRNAs previously shown to elicit a range of off-target effects ([@B25]). We found that d-siRNAs and e-siRNAs produce minimal off-target effects as compared to chemically synthesized siRNAs.

MATERIALS AND METHODS
=====================

Preparation of siRNAs, d-siRNAs, and e-siRNAs
---------------------------------------------

The 14-1, 14-5, and 14-8 siRNAs ([Table 1](#T1){ref-type="table"}) were purchased from Ambion (Austin, TX) as deprotected, desalted duplexes. The d-siRNAs were prepared as previously described ([@B43]). Briefly, PCR was used to generate *in vitro* transcription templates. The T7 promoter (underlined in [Table 1](#T1){ref-type="table"}) was added to the 5′-end of both the sense and antisense strand via PCR. Using MegaScript reagents, T7 polymerase (Cat. No. 1334, Ambion) was used to transcribe the sense and antisense RNA strands, which anneal during transcription. Recombinant human Dicer ([@B43]) was used to cleave the large dsRNA into d-siRNA by incubation for 16 hr at 37°C. Recombinant bacterial RNase III (Cat. No. 2290, Ambion) was used to cleave large dsRNA into e-siRNA by incubation for 2 hr at 37°C as described by the manufacturer ([@B35]). The Micro-to-midi RNA purification system (Cat. No. 12183-018, Invitrogen; Carlsbad, CA) was used to purify the d-siRNAs and e-siRNAs as described previously ([@B43]).

###### 

siRNAs, d-siRNAs, and e-siRNAs

  siRNA2   Sense strand                    Antisense strand                Position relative to start codon
  -------- ------------------------------- ------------------------------- ----------------------------------
  14-1     5′-CCUACAGAGAACUGCGGUUdTdT-3′   5′-AACCGCAGUUCUCUGUAGGdTdT-3′   203-221
  14-5     5′-CCAGUGGCCGAUCCUUAUGdTdT-3′   5′-CAUAAGGAUCGGCCACUGGdTdT-3′   952-970
  14-8     5′-GGCCUUUUCACGGGAACUCdTdT-3′   5′-GAGUUCCCGUGAAAAGGCCdTdT-3′   1129-1147
  GL3      5′-CUUACGCUGAGUACUUCGAdTdT-3′   5′-UCGAAGUACUCAGCGUAAGdTdT-3′   155-173

  Diced pools   Sense primer                        Antisense strand                    Position relative to start codon
  ------------- ----------------------------------- ----------------------------------- ----------------------------------
  d-14-1        5′-[GCGTAATACGACTCACTATAGG]{.ul}-   5′-[GCGTAATACGACTCACTATAGG]{.ul}-   1-551
                ATGTCTCAGGAGAGGCCCAC-3′             GCCGCGTAGCCTGTCATTTC-3′             
  d-14-5        5′-[GCGTAATACGACTCACTATAGG]{.ul}-   5′-[GCGTAATACGACTCACTATAGG]{.ul}-   552-1082
                CACTAGGTGGTACAGGGCTC-3′             CAGGACTCCATCTCTTCTTGG-3′            
  d-14-8/       5′-[GCGTAATACGACTCACTATAGG]{.ul}-   5′-[GCGTAATACGACTCACTATAGG]{.ul}-   1087-1638
  e-14-8        CCTGGTTTCTGTTCTGTTGATCCC-3′         TAAGCAAGTTAATCACAGGCTAGTGC-3′       
  GL3           5′-[GCGTAATACGACTCACTATAGG]{.ul}-   5′-[GCGTAATACGACTCACTATAGG]{.ul}-   114-615
                AACAATTGCTTTTACAGATGC-3′            AGGCAGACCAGTAGATCC-3′               

Cloning individual d-siRNAs
---------------------------

d-siRNAs for human cyclin B1 were generated from bases 820-1479 of the open reading frame as described ([@B43]). d-siRNAs were cloned using a strategy adapted from Elbashir et al ([@B16]). 2 μg of d-siRNAs were gel purified, extracted from a 12% (w/v) urea gel and precipitated with absolute ethanol. Purified products were ligated to 5 μM of 3′ adapter oligonucleotides (Dharmacon, Lafayette CO) with T4 RNA ligase (NEB), purified, gel extracted from a 12% (w/v) urea gel and subjected to phosphorylation with T4 polynucleotide kinase (NEB). Phosphorylated products were ligated to 5 μM of 5′ adapter oligonucleotides (Dharmacon) and purified by phenol/chloroform extraction followed by precipitation with 10 M ammonium acetate. Ligated products were subjected to reverse transcription (Superscript III First-Strand Synthesis Kit, Invitrogen) using 3′ oligo (5′GACTAGCTGGAATTCAAGGATGCGGTTAAA), and then amplified by PCR using 5′ oligo (5′CAGCCAACGGAATTCATACGACTCACTAAA) and 3′ oligo (5′GACTAGCTGGAATTCAAGGATGCGGTTAAA). Amplified products were then cloned into pCR 2.1-TOPO (Invitrogen), and positive clones were screened by PCR and sequenced using M13 forward and reverse primers.

Cell culture and transfections
------------------------------

HeLa cells (Cat. No. CCL-2, ATCC; Manassas, VA) were cultured at 37°C and 5% (v/v) CO~2~ in Dulbecco\'s modified Eagle\'s media (DMEM, Cat. No. 11995-65, Invitrogen) containing 10% (v/v) fetal bovine serum (FBS, Cat. No. 26140-079, Invitrogen), 100 U/ml penicillin, 100 μg/ml streptomycin, and additional 4 mM glutamine (Cat. No. 10378-016, Invitrogen). HeLa cells were plated at ∼30% confluence whenever a density of ∼80% confluence was attained in order to maintain logarithmic growth. Transfections were carried out with GeneSilencer (Cat. No. T500750, Genlantis; San Diego, CA) as previously described ([@B43]). Briefly, ∼8 × 10^4^ HeLa cells were plated per well in 6-well dishes 18-24 hr prior to transfection. Shortly before transfection, serum-containing medium was removed, cells were rinsed twice with 2 ml of Opti-mem I (31985-070, Invitrogen) followed by addition of 1 ml of Opti-mem I. For most experiments, siRNAs, d-siRNAs, and e-siRNAs were mixed with GeneSilencer transfection reagents and added to cells such that the final concentration was 10 nM. Other final concentrations of siRNAs/d-siRNAs/e-siRNAs were used for the experiments shown in [Figure 1](#F1){ref-type="fig"}. Three hours and 30 min after addition of transfection mix, DMEM containing 20% (v/v) FBS, 200 U/ml penicillin, 200 μg/ml streptomycin, and additional 8 mM glutamine was added to each well to restore each component to normal concentrations. Cells were also treated with transfection reagent alone, subjected to the media change to Opti-mem I, or left untreated.

![Complexity of d-siRNA pool. (**A**) A 660 bp fragment of the human cyclin B1 dsRNA was digested *in vitro* with human recombinant Dicer. Sixty of the resulting siRNAs were cloned and sequenced. (**B**) The predicted frequencies of cloning individual siRNAs once, twice, three times, or four times, out of a sample of 60 clones, for three different assumed pool complexities (c=31, 200, 640). The observed frequencies (open circles) fit best to a pool complexity of 200.](jrgs-02-181-g001){#F1}

Preparation of cellular extracts and purification of total RNA
--------------------------------------------------------------

The PARIS kit (Cat. No. 1921, Ambion) was used to produce total cellular extract and purify total RNA as described by the manufacturer. About 48 hr after transfection, cells were lysed with cell disruption buffer (PARIS) containing protease inhibitors ([@B43]). One-third of the lysate was saved for analysis of protein. Total RNA was isolated from the remaining two-thirds.

SDS-PAGE and western blotting
-----------------------------

The total amount of protein in each cell lysate was measured with the BCA protein assay kit (Cat. No. 23225, Pierce Biotechnology; Rockford, IL). The volume of each lysate was adjusted with cell disruption buffer (PARIS) containing protease inhibitors such that the total protein concentration of each lysate was equal. After addition of Laemmli sample buffer about 15 μg of total protein per lane was electrophoresed in a 10% (w/v), 29:1 (acrylamide:bisacrylamide) SDS polyacrylamide gel ([@B43]). Proteins were transferred to Immobilon-P polyvinylidine fluoride membrane (PVDF, Millipore, Billerica, MA) in 25 mM Tris, 192 mM glycine, and 10% (v/v) methanol. Antibodies were diluted in Dulbecco\'s phosphate-buffered saline (D-PBS, Cat. No. 14040-182, Invitrogen) containing 1% (w/v) non-fat milk powder and 0.01% (v/v) Tween-20 (Cat. No. P1379 Sigma-Aldrich; St. Louis, MO). Affinity purified p38α MAPK IgG (Cat. No. SC-535, Santa Cruz Biotechnology, Santa Cruz, CA) was used at 1:1000 dilution (0.2 μg/ml), MEK1 antiserum 662 ([@B23]) was used at 1:2000, and affinity purified IgG raised against eIF2α phosphorylated at serine 51 (cat. No. 44-728G, Biosource International; Camarillo, CA) was used at a 1:500 dilution (0.5 μg/ml). Horseradish peroxidase (HRP) conjugated goat IgG raised against rabbit IgG (Cat. No. 81-6120, Zymed, San Francisco, CA) was used at a 1:5000 dilution (0.3 μg/ml) for detecting MEK1 and p38α MAPK or a 1:2500 dilution (0.6 μg/ml) for detection of phosphorylated eIF2α. Immun-Star HRP chemiluminescence kit (Cat. No. 170-5040, BioRad, Hercules, CA), a GelDoc (BioRad), and the QuantityOne software package (BioRad) were used for visualizing and quantifying MEK1, p38α MAPK, and phosphorylated eIF2α abundance.

Microarray hybridization and data analysis
------------------------------------------

Fluorescently-labeled cDNA was synthesized from RNA isolated from cells transfected with one of the siRNAs, d-siRNAs, or e-siRNAs. A reference set of fluorescently-labeled cDNAs was prepared from RNA that was isolated from HeLa cells treated with the GeneSilencer transfection reagent only. Comparative hybridization to a cDNA microarray with 41,421 spots from 24,472 unique putative genes (based on cluster ID) was then used to identify mRNAs whose levels were different in siRNA-treated cells compared to the reference control.

To obtain sufficient quantities of mRNA for microarray hybridization, polyadenylated transcripts from all samples, including the reference, were amplified using the MessageAmp aRNA kit (Cat. No. 1750, Ambion) after any residual DNA was removed from isolated total RNA with RNase-free DNase provided in the DNA-free kit (Cat. No. 1906, Ambion). Using standard protocols the amplified RNA (aRNA) made from cells transfected with one of the small dsRNAs was subjected to reverse-transcription in the presence of random hexamers (Cat. No. 27-2166-01, Amersham, Piscataway, NJ) and Cy5-labeled d-UTP (Cat. No. 55022, Amersham) to produce fluorescently labeled cDNA probes. Similarly the reference aRNA was reverse-transcribed in the presence of random hexamers and Cy3-labeled d-UTP (Cat. No. 53022, Amersham) to produce a second set of fluorescently labeled cDNA probes. The fluorescent probes were then comparatively hybridized (without fragmentation) to cDNA micorarrays as previously described ([@B11]; [@B59]).

For each of the 54 microarrays, mRNA abundance measurements were independently normalized within each array such that the mean Cy5:Cy3 ratio was 1. Measurements of mRNA abundance were considered good if the regression correlation between the Cy5 and Cy3 fluorescence intensity across the pixels comprising the scanned image of the corresponding array elements was greater than 0.6, if the mean intensity of Cy3 was 2-fold greater than the median background Cy3 intensity, and if the Cy5 normalized mean intensity was 2-fold greater than the median background Cy5 intensity.

Significance analysis of microarrays (SAM) ([@B57]) was used to identify mRNAs for which consistent differences were observed between treatments. For [Figure 4](#F4){ref-type="fig"}A, the p38αMAPK siRNAs/d-siRNAs/e-siRNAs were taken as one class and were compared to a second class comprising the GL3 controls. For [Figure 4](#F4){ref-type="fig"}B, ten separate SAM analyses were performed, with each individual treatment considered to be one class and compared to a second class comprising all of the other treatments. Cluster analysis ([@B14]) was used to organize the heat maps.

Complete microarray data can be found in the Stanford Microarray Database (http://genome-www5.stanford.edu/).

RESULTS
=======

d-siRNA pools are highly complex
--------------------------------

We began by estimating the complexity of a diced pool of siRNAs. Filpowicz and co-workers have shown that recombinant human Dicer prefers to cleave dsRNA substrates at their free termini ([@B62]). Thus, after short periods of digestion the complexity of a diced pool might be relatively low. However, for gene silencing experiments, *in vitro* dicing reactions are generally carried out for long periods of time to maximize the yield of 21 bp products ([@B43]). Under these conditions, the complexity of the pool could be high.

We diced to completion (16 hr) a 660 bp dsRNA fragment derived from the human cyclin B1 open reading frame. The d-siRNAs were cloned using a strategy adapted from Elbashir et al, and 60 clones were isolated and sequenced. The higher the complexity of the 660 bp pool, the lower the odds are of obtaining any individual siRNA sequence more than once. If the 60 clones sequenced represent a random sample of the pool, the Poisson distribution describes the odds of obtaining any individual siRNA sequence, once, twice, or more than twice, for any assumed complexity. If the complexity is assumed to be 31 (the minimum number of 21-mers required to span 660 bp), then 9/60 sequences would be expected to be obtained once, 8/60 twice, 5/60 three times, and so on ([Figure 1](#F1){ref-type="fig"}B). On the other hand, if the complexity is assumed to be 640 (the maximum number of 21-mers that can be obtained from a 660 bp dsRNA), then 55/60 would be expected to be obtained once, and 2 or 3 twice ([Figure 1](#F1){ref-type="fig"}B). By fitting Poisson distribution curves to the experimentally observed distribution of sequences and minimizing the variance between the observed and predicted distributions, an estimate can be obtained for the complexity of the pool. If some siRNAs in the pool are easier to clone than others, then the estimate will be a lower bound for the true complexity.

As shown in [Figure 1](#F1){ref-type="fig"}A and [Supplementary Table 1](#SD1){ref-type="supplementary-material"}, the 60 sequences were distributed throughout the 660 bp dsRNA. There was a "hot spot" about 380 nt from the 5′ end of the dsRNA, from which 13 of the 60 sequences were cloned. This could represent a region of preferred Dicer cleavage or a region whose sequences were most easily cloned. Most of the sequences were 21 nt in length (60%), and most of the sequences were obtained only once: 44 were isolated once, 5 were isolated twice, 2 were isolated three times, and none were isolated more than three times. This distribution yields an estimated complexity of 200 different siRNAs in the pool. Note that if the cloning process was biased towards particular sequences (like the 13 "hot spot" sequences), the actual complexity would be higher than the estimated complexity. We carried out a similar analysis on a second 660 bp dsRNA, and obtained similar results. Thus, diced siRNA pools are highly complex.

Potencies of the synthetic, diced, and RNase III-generated siRNAs
-----------------------------------------------------------------

We purchased three p38α MAPK siRNAs that had been studied in previously published work ([@B25]): 14-5, which was reported to alter the levels of a large number of off-target mRNAs; 14-8, which was intermediate in terms of the number of mRNAs affected and whose off-target profile was qualitatively distinct from that of 14-5; and 14-1, which produced the least severe off-target effects ([Table 1](#T1){ref-type="table"}, [Figure 2](#F2){ref-type="fig"}A). We also transcribed three ∼550 bp p38α MAPK dsRNAs, ([Table 1](#T1){ref-type="table"}, [Figure 2](#F2){ref-type="fig"}A) and subjected them to digestion with recombinant Dicer. In addition, one of the three ∼550 bp dsRNAs was subjected to digestion with RNase III. These ∼550 bp regions encompassed each of the three synthetic siRNAs ([Figure 2](#F2){ref-type="fig"}A) and contained stretches of identity to various p38α MAPK-related genes and to some unrelated genes as well. For example, the 551 bp region containing siRNA 14-1 included 26 consecutive nucleotides of identity to p38β MAPK, 20 nucleotide stretches of identity to p38γ MAPK and p38δ MAPK, 17 nucleotides to the alkaline phosphatase ALPI and to MAP3K7; the 531 bp region containing siRNA 14-5 included 20 consecutive nucleotides of identity to p38β MAPK, 17 nucleotides to the trithorax-related gene MLL, and 16 nucleotides to ERK1 and p38δ MAPK; and the 552 bp region containing siRNA 14-8 included 19 consecutive nucleotides of identity to MLL, 17 nucleotides to CD44 and the putative amidase FLJ31204, 12 nucleotides to p38β MAPK, and 11 nucleotides to the angiomotin-like gene AMOTL1. Thus each long dsRNA region has the potential to produce the same off-target effects as one of the three synthetic siRNAs, plus additional off-target effects due to cross-hybridization to a subset of these ten other genes.

![Silencing p38α MAPK expression with synthetic siRNAs, d-siRNAs, and e-siRNAs. (**A**) Schematic of the p38α MAPK cDNA and the sequences targeted by the siRNAs, d-siRNAs, and e-siRNA employed here. The lengths of the cDNA, siRNAs, and pools are drawn to scale. (**B**) Dose-dependent decreases in p38α MAPK protein levels in HeLa cells transfected with siRNAs, d-siRNAs, and e-siRNAs. Equivalent amounts of whole cell lysates were subjected to SDS-PAGE and immunoblotted with MEK1 antiserum (a loading control) or a p38α MAPK antibody. (**C**) Band intensity was quantified, normalized to the respective control (a GL3 luciferase-derived siRNA as the synthetic control, and Dicer- or RNase III-generated luciferase d-siRNAs/e-siRNAs as the other controls), and plotted as dose/inhibition curves.](jrgs-02-181-g002){#F2}

Dicer produced a mix of diced siRNAs (d-siRNAs) of approximately 21-22 bp, whereas RNase III produced a mix of siRNAs (e-siRNAs) with a more heterogenous size distribution (15-30 bp) (data not shown). Various concentrations of the synthetic siRNAs and these d-siRNA/e-siRNA pools were transfected into HeLa cells. As controls, we transfected a synthetic GL3 luciferase siRNA (si-GL3), an *in vitro* diced GL3 control (d-GL3), or an RNase III-generated GL3 control (e-GL3). Cells were lysed 48 hr after transfection and lysates were immunoblotted with antibodies against p38α MAPK and MEK1, a constant-abundance protein of similar molecular mass used as a loading control.

As shown in [Figures 2B and C](#F2){ref-type="fig"}, the potencies of the various siRNAs and siRNA pools were similar, with synthetic siRNA 14-8 and diced pool d-14-8 being the most potent and RNase III-treated pool e-14-8 being the least potent. At a final concentration of 10 nM the various siRNAs reduced p38α MAPK protein levels by ∼50-70%. Since this amount of silencing was comparable to those attained in previous studies of siRNA off-target effects ([@B25]) and higher siRNA doses may be problematic ([@B50]), we decided to assess the off-target profiles of all of the siRNAs and pools at this concentration.

Global analysis of mRNA changes
-------------------------------

HeLa cells were transfected in triplicate with p38α MAPK siRNAs (14-1, 14-5 or 14-8), d-siRNAs (d-14-1, d-14-5 or d-14-8), e-siRNAs (e-14-8), or control luciferase-derived siRNAs. Lysates were aliquoted for immunoblot analysis (for p38α MAPK, MEK1, and eIF2α, a marker of non-specific repression of translation) and for global analysis of mRNA levels. Each of the p38α MAPK siRNAs and pools produced a ∼50-70% decrease in p38α MAPK protein levels and a ∼30-40% decrease in p38α MAPK mRNA levels ([Figure 3](#F3){ref-type="fig"}A). No significant changes in p38α MAPK protein or mRNA levels were seen in the control-treated cells ([Figure 3](#F3){ref-type="fig"}A). None of the treatments elevated the levels of eIF2α phosphorylation ([Figure 3](#F3){ref-type="fig"}A), arguing that the siRNA-induced decreases in p38α MAPK levels were not due to phospho-eIF2α-mediated global inhibition of translation.

![Global changes in gene expression in siRNA-treated cells. (**A**) Decreases in p38α MAPK mRNA and protein levels. mRNA levels were measured by microarray analysis and data from three experiments are shown. Protein levels were also assessed in triplicate; one representative blot, showing p38α MAPK levels, MEK1 levels, and eIF2α phosphorylation, is shown here. (**B-D**) Distributions of mRNA levels. (**E**) Standard deviations of the mRNA distributions.](jrgs-02-181-g003){#F3}

In the microarray analysis, a total of 34,944 spots were considered well-measured (green channel mean intensity \>2-fold over green channel median background intensity; red channel mean intensity \>2-fold over red channel median background intensity; regression correlation between red and green pixels, for each spot, \>0.6). Of these, 9538 spots, corresponding to 7587 different genes, were measured in all 30 arrays (10 siRNA treatments assessed in triplicate). We also carried out a triplicate analysis of mock-transfected cells in a separate experiment, with 7257 out of the 9538 mRNA spots considered well-measured in all three replicates. As shown in [Table 2](#T2){ref-type="table"} and [Figure 3](#F3){ref-type="fig"}B-E, the mock-transfected cells showed little variation in mRNA levels. None of the 7257 mRNAs changed by more than 2-fold ([Table 2](#T2){ref-type="table"}), and the log-ratio distribution showed a narrow, symmetrical peak centered close to zero ([Figure 3](#F3){ref-type="fig"}B-D). The standard deviation of the log-ratio distribution was 0.17, which means that 68% of the mRNAs were measured at between 89% and 112% of their baseline levels. This can be regarded as the intrinsic variability of the mRNA isolation and microarray quantification procedures.

###### 

Global changes in mRNA levels in cells treated with diced siRNAs, RNase-III siRNAs and synthetic siRNAs

                                                              GL3 controls   Diced siRNAs   RNase III   Synthetic siRNAs                                       
  ---------------------------------------------------- ------ -------------- -------------- ----------- ------------------ ----- ------ ------ ------ -------- -------
  Number of mRNAs that changed more than 2-fold        0      0              0              13          5                  4     1      0      1      123      57
  Number of mRNAs that decreased more than p38α MAPK   1820   3653           3330           3329        32                 23    18     93     47     428      171
  Number of mRNAs that changed significantly by SAM    \-     0±0            4±1            33±1        7±1                9±2   12±1   11±4   35±1   1105±1   322±1

A total of 9538 mRNA spots (corresponding to 7587 different genes) were considered well-measured in all 30 siRNA-treated samples. Of those, 7257 spots were also well-measured in the three mock-transfected samples. The ranges shown for the number of mRNAs that changed significantly by SAM are calculated from the estimated false discovery rate.

All of the cells treated with siRNAs showed somewhat greater variation in mRNA levels, as indicated by a slight broadening of the log-ratio distribution ([Figure 3](#F3){ref-type="fig"}B-D) and an increase in the distributions\' standard deviations ([Figure 3](#F3){ref-type="fig"}E). These changes were most noticeable in the cells treated with two of the synthetic siRNAs, 14-5 and 14-8 ([Figure 3](#F3){ref-type="fig"}D-E and [Table 2](#T2){ref-type="table"}). Whereas none of the mRNAs changed by more than 2-fold in the mock-treated cells and the cells treated with control d-GL3 and e-GL3 siRNA pools, a total of 123 mRNA spots out of 9538 changed by more than 2-fold in the 14-5-treated cells ([Table 2](#T2){ref-type="table"}). Moreover, 428 mRNAs out of 9538 were suppressed to a greater extent than the intended target, p38? MAPK ([Table 2](#T2){ref-type="table"}). Synthetic siRNA 14-8 induced fewer, but still substantial, changes in mRNA levels; 57 mRNAs changed by more than 2-fold and 171 mRNAs decreased more than p38α MAPK.

The remaining synthetic siRNA (14-1) and all of the diced siRNAs exhibited minimal global changes in gene expression. The number of mRNAs suppressed more than p38α MAPK ranged from 18 (for diced siRNA d-14-8) to 47 (for synthetic siRNA 14-1) out of 9538, and the number of mRNAs varying more than 2-fold ranged from one to five ([Table 2](#T2){ref-type="table"}). Thus, in comparison to siRNAs 14-5 and 14-8, the changes in mRNA levels produced by the diced pools were minimal. The RNase III-generated siRNA pool (e-14-8) had mild off-target effects (no mRNAs changed by more than 2-fold), but because it was the least effective at silencing the target p38α MAPK gene, a relatively high number of mRNAs were suppressed more than the target was (93 out of 9538; [Table 2](#T2){ref-type="table"}).

Secondary effects and off-target effects
----------------------------------------

Some of the changes in mRNA levels could be secondary to the suppression of p38α MAPK. Such secondary effects would be expected to occur in all of the samples treated with p38α MAPK siRNAs/d-siRNAs/e-siRNAs, and not in the samples treated with luciferase siRNAs/d-siRNAs/e-siRNAs. To identify potential secondary changes, we divided the data into two classes, with the d-GL3-, e-GL3-, and si-GL3-treated cells (9 experiments) constituting one class and the d-14-1-, d-14-5-, d-14-8-, e-14-8-, 14-1-, 14-5-, and 14-8-treated cells (21 experiments) constituting the other. We then applied the significance analysis of microarrays (SAM) method ([@B57]), a modified *t*-test that compares how much an mRNA changes between the two classes to its variability within each class, thereby identifying mRNAs whose between-class changes are statistically significant ([@B57]). The mRNAs identified by SAM should include the intended target mRNA (p38α MAPK) and any secondary mRNAs.

[Figure 4](#F4){ref-type="fig"}A shows the mRNAs that decreased (top) and increased (bottom) significantly, where we took a maximum SAM q-value of 25% as our cutoff for significant changes. The mRNAs identified included the intended target, p38α MAPK, two other suppressed mRNAs and five induced mRNAs ([Figure 4](#F4){ref-type="fig"}A). At least two of the mRNAs (ARK5 and CREB3L1) are connected to the p38α MAPK pathway in ways that suggest possible feedback roles (positive and negative, respectively). All in all, the number of candidate secondary mRNAs was small, amounting to 7 out of the 9538 mRNAs deemed well-measured.

![Secondary and off-target effects in cells treated with siRNAs, d-siRNAs, and e-siRNAs. Cells were transfected with various siRNAs and pools at a final concentration of 10 nM and were subjected to microarray analysis. (**A**) Putative secondary effects. The samples whose p38α MAPK mRNA was suppressed were compared to the GL3 control samples by significance analysis of microarrays (SAM) ([@B57]) in order to identify mRNAs whose expression is regulated by p38α MAPK. (**B**) Off-target effects. Ten SAM analyses were carried out, comparing each of the treatments (3 experiments) to the other nine (27 experiments). No significant mRNA changes were detected for one of the treatments (d-GL3). For the other treatments, the mRNAs that changed significantly are represented as heat maps. The treatment to which each heat map corresponds is indicated on the left; for example, the comparison of e-GL3 to the other treatments is shown at the top, and the largest heat map compares the 14-5-treatment to the others. Within each heat map, the mRNAs are organized by clustering.](jrgs-02-181-g004){#F4}

To identify siRNA-specific off-target effects, we performed ten SAM analyses, with each treatment (3 experiments) compared to all other treatments (27 experiments) and the p38α MAPK mRNA and the putative secondary mRNAs excluded from consideration. The results are shown in [Table 2](#T2){ref-type="table"} and [Figure 4](#F4){ref-type="fig"}B. One of the treatments, the d-GL3 control, produced no significant changes in mRNA levels. Moreover, none of the d-siRNAs or e-siRNAs caused more than twelve significant changes ([Table 2](#T2){ref-type="table"}). None of the ten mRNAs mentioned above as potentially cross-hybridizing to one or more of the siRNA pools (p38β MAPK, p38γ MAPK, p38δ MAPK, MLL, ALPI, MP3K7, ERK1, AMOTL1, CD44, and FLJ31204) was found to change significantly.

In contrast, the synthetic siRNAs affected larger numbers of mRNA levels. The si-GL3 control produced 33 significant changes and the p38α MAPK siRNAs produced 35 changes (14-1), 1105 changes (14-5), and 322 changes (14-8). There was a small degree of overlap between the mRNAs affected by 14-5 and 14-8, but for the most part the profiles of mRNAs were distinct, arguing that the effects were specific to particular siRNA sequences rather than shared by synthetic siRNAs in general. For those features we found significant by SAM, there was a reasonable correlation between the changes in mRNA abundance seen here and those reported previously ([@B25]), with Pearson correlation coefficients of 0.64, 0.54, and 0.71 for 14-1, 14-5, and 14-8 respectively. Note that different luciferase-derived siRNAs were used in the two studies and therefore results were not compared.

To test the idea that off-target silencing of the siRNAs was due to short stretches of sequence identity with the off-target mRNAs, we characterized the degree of identity between the four synthetic siRNAs and the 173 most highly-suppressed off-target mRNAs. Almost all of the suppressed mRNAs possessed a stretch of at least 6 nucleotides of identity (97%) with the relevant siRNA, and almost none of the suppressed mRNAs possessed a stretch of 11 or more (1%), with an average of 7.4 + 1.1 (S.D.) consecutive nucleotides. This is consistent with the possibility that short stretches of identity mediate the off-target effects. However, a control group of 172 unaffected mRNAs showed the same extent of identity to the siRNAs: 98% had a stretch of at least 6 nucleotides, 1% had a stretch of 11 or more, and the average was 7.3 ± 1.1 (S.D.). Thus, as a group, the suppressed mRNAs were no more likely to possess a long stretch of sequence identity with the relevant siRNAs than the unaffected mRNAs were.

Others have also recently shown that exact or near-exact matches between either strand of an siRNA and off-target mRNAs could not explain the unintentional reduction in nontargeted mRNAs ([@B2]). Instead one or more exact matches between the hexamer or hepatamer seed region of the siRNA (positions 2-7 or 2-8 from the 5′-end) and the 3′-UTR of the off-target mRNAs occurred at a greater frequency than matches between the seed region and the 3′-UTR of untargeted mRNAs. Using the Birmingham et al. siRNA seed locator ([@B2]), we found that this model can explain at least some of the off-target changes we observed. Treatment with 14-5 and 14-8 reproducibly decreased the abundance of 239 and 216 different transcripts, respectively ([Table 3](#T3){ref-type="table"}). 42 of the 239 transcripts unintentionally reduced by 14-5 contained one seed match in the 3′-UTR whereas only 19 of 240 randomly chosen transcripts contained a seed match (P \< 0.01 using χ^2^ test). Of these 42 mRNAs, 10 were present in a previous study of the effects of 14-5 ([@B25]), and 7 of the 10 decreased in that study as well as ours ([Supplementary Figure 1](#SD2){ref-type="supplementary-material"}). Additionally, 47 of the 216 mRNAs reduced by 14-8 contained one seed match in the 3′-UTR in contrast to 20 of the 240 untargeted transcripts (P \< 0.001 using χ^2^ test). Of these 47 mRNAs, 31 were present in a previous study of the effects of 14-8 ([@B25]), and 20 of the 31 decreased in that study as well as ours ([Supplementary Figure 1](#SD2){ref-type="supplementary-material"}). Treatment with the GL3 and 14-1 siRNAs reproducibly decreased the abundance of smaller numbers of transcripts, 33 and 35 respectively ([Table 3](#T3){ref-type="table"}). In each case three of these untargeted transcripts contained seed matches, which is not significantly different from the number of matches in 33 or 35 random sequences. Finally multiple seed matches in the 3′-UTRs of off-target transcripts were enriched relative to untargeted transcripts only in the cells treated with 14-8 siRNA ([Table 3](#T3){ref-type="table"}).

###### 

siRNA seed matches to 3′-UTR can explain some but not all siRNA induced off-target effects.

                                                                 siRNA          
  ------------------------------------------------------- ------ ------- ------ -------
  Number of single seed matches to 3′UTR human genome     1187   1463    4460   4967
  Number of multiple seed matches to 3′UTR human genome   55     124     927    1012
  Number of mRNAs that were significantly reduced (SAM)   34     35      239    216
  Number of SAM mRNAs with single seed match              3      3       42     47
  Number of random mRNAs with single seed match           1      1       19     20
  P-value (χ^2^ test)                                     1      1       0.01   0.001
  Number of SAM mRNAs with multiple seed match            0      0       10     16
  Number of random mRNAs with multiple seed match         0      0       7      4
  P-value (χ2 test)                                       1      1       1      0.01

In summary, a range of off-target effects were seen with the synthetic siRNAs; two had relatively minor effects (the si-GL3 control and 14-1) and two had marked effects (14-5 and 14-8). These findings agree qualitatively with previously published findings ([@B25]). In contrast, all of the d-siRNA and e-siRNA pools examined here were nearly free of off-target effects.

Diluting siRNAs into a d-siRNA pool minimizes off-target effects
----------------------------------------------------------------

We hypothesized that the d-siRNA and e-siRNA pools had such minimal off-target effects because each unique siRNA within a pool is present at a low absolute concentration. If, for example, sequence-specific off-target effects are mediated by the binding of an siRNA to an eight-nucleotide stretch of mRNA sequence, only 15 out of the 529 possible 22-mers that could be derived from digestion of a 550 bp dsRNA (\< 3% of the total) would be expected to also match that eight-nucleotide sequence. Thus at a total concentration of 10 nM d-siRNA, the concentration of siRNAs complementary to a given eight-nucleotide sequence would be less than 0.3 nM. This might be too low to result in detectable off-target effects. If more than eight consecutive nucleotides of identity are required for off-target effects, the absolute concentration of potentially cross-hybridizing 22-mers would be even lower.

To test these ideas, we added the synthetic siRNA with the most prominent off-target effects (14-5) to the corresponding diced pool (d-14-5) at dilutions of 1:3, 1:30, or 1:300, and then transfected these mixtures in triplicate into HeLa cells at a final total RNA concentration of 10 nM. We also added the 14-5 synthetic siRNA to a diced luciferase siRNA pool at the same dilutions. We then analyzed p38α MAPK levels, MEK1 levels, and eIF2α phosphorylation levels in all of the samples, and subjected cells transfected with 14-5, 14-5/d-14-5 mixtures, and various control siRNAs to microarray analysis.

Consistent with previous experiments ([Figures 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}), 14-5, 14-8 and d-14-5 were found to reduce p38α MAPK protein levels by 60-70% relative to treatment with d-GL3 or transfection reagent alone ([Figure 5](#F5){ref-type="fig"}A). Similar silencing of p38α MAPK was seen in the samples treated with mixtures of 14-5 and d-14-5 ([Figure 5](#F5){ref-type="fig"}A). In contrast, silencing was reduced when 14-5 was diluted with an irrelevant diced luciferase control ([Figure 5](#F5){ref-type="fig"}A). The level of eIF2α phosphorylation was similar to mock transfected cells in all cases ([Figure 5](#F5){ref-type="fig"}A).

![Off-target effects are titratable. (**A**) Changes in p38α MAPK protein levels. HeLa cells were transfected in triplicate with the siRNAs and pools shown, all at a final concentration of 10 nM. One representative immunoblot, showing MEK1 levels (loading control), p38α MAPK levels, and eIF2α phosphorylation is shown along with quantitative p38α MAPK data from all three replicates. Data are plotted as means ± S.D. (**B**) Fluorescence intensity data from the microarray experiments. The 1105 mRNAs identified as changing significantly in the SAM analysis of 14-5 vs. the other treatments (shown in [Figure 4](#F4){ref-type="fig"}B) were used for the heat map shown here. Genes that were not well-measured in one or more samples are omitted from the heat map.](jrgs-02-181-g005){#F5}

We then carried out microarray analysis and focused on the mRNAs whose levels had been previously shown to change significantly in the 14-5-treated samples ([Figure 4](#F4){ref-type="fig"}B). The pattern of mRNA changes induced by 14-5 ([Figure 5](#F5){ref-type="fig"}B) was qualitatively similar to that seen in [Figure 4](#F4){ref-type="fig"}B. Dilution of the 14-5 siRNA by a factor of 3 with d-14-5 decreased, but did not eliminate, this pattern of off-target changes ([Figure 5](#F5){ref-type="fig"}B) without decreasing the amount of on-target suppression the p38α MAPK mRNA ([Figure 5](#F5){ref-type="fig"}A). Dilution of the 14-5 siRNA by a factor of 30 or 300 with d-14-5 rendered the off-target signature undetectable ([Figure 5](#F5){ref-type="fig"}B), again without decreasing the amount of suppression of p38α MAPK. We noted that in one of the three 1:300 dilution experiments there were some changes in mRNA levels ([Figure 5](#F5){ref-type="fig"}B), but the changes were irreproducible and distinct from the 14-5 off-target signature and therefore were attributed to experiment-to-experiment variation. Thus, the minimal off-target effects seen with diced siRNAs can be rationalized on the basis of dilution of individual problematic siRNAs to insignificant absolute concentrations.

DISCUSSION
==========

Here we have confirmed previous studies ([@B25]) showing that individual siRNAs can produce substantial off-target changes in mRNA abundance ([Figures 4](#F4){ref-type="fig"}-[5](#F5){ref-type="fig"}). Some of the observed decreases in mRNA abundance may be due to cross-hybridization to seed sequences in the off target mRNA 3′-UTRs ([Table 3](#T3){ref-type="table"}), as previously hypothesized ([@B2]). In support of this idea, the seed sequences from the more problematic individual siRNAs (14-5 and 14-8) had more matches to 3′-UTR sequences than did the least problematic individual siRNA (14-1). Other mechanisms might explain the observed increases in some mRNAs and the changes in the abundances of mRNAs that had no obvious cross-hybridization potential. Because these other mechanisms are incompletely understood, it is not possible to develop siRNA design algorithms that would ensure siRNA specificity.

Irrespective of the exact mechanism(s) of off-target effects of individual siRNAs, complex d-siRNA pools are essentially free of off-target effects ([Figure 4](#F4){ref-type="fig"}), even when the diced pool is known to contain a problematic siRNA ([Figure 5](#F5){ref-type="fig"}). The simplest explanation for the low off-target effects of d-siRNAs is that although an siRNA pool contains hundreds of different siRNAs ([Figure 1](#F1){ref-type="fig"}), all of which would be expected to hybridize with the intended target, very few of them would be expected to cross-hybridize to any particular off-target gene or to exert some other sequence-specific off-target effect such as an aptamer effect. A 1:3 dilution of a problematic individual siRNA caused a decrease in the magnitude of its off-target effects, but higher dilutions were needed to eliminate them ([Figure 5](#F5){ref-type="fig"}) suggesting that the complexity of pools is essential to attaining specific gene silencing.

The low incidence of off-target effects in HeLa cells treated with diced siRNAs agrees well with the general impression of high specificity in *C. elegans* and *Drosophila* gene silencing, where large dsRNAs, which act after being converted to complex pools of siRNAs by the endogenous Dicer protein, are routinely used. The minimal off-target effects of d-siRNAs make them a particularly attractive method for the transient suppression of gene expression in applications like large scale screening experiments where it might not be feasible to assess the off-target effects of every siRNA or siRNA pool used.

Finally, it should be emphasized that even when an siRNA or siRNA pool produces no off-target changes in mRNA abundance, it is still possible that it will affect the translation of off-target mRNAs. Thus, although freedom from off-target mRNA effects is certainly desirable for gene silencing experiments, it is not sufficient to guarantee specificity. The use of multiple siRNAs or siRNA pools, and the rescue of an RNAi-induced phenotype with an RNAi-resistant construct (*e.g.*, a 3′-UTR-directed d-siRNA pool (like d-14-8) combined with a rescue construct lacking the 3′-UTR) remain important approaches for establishing the specificity of an RNAi-induced phenotype.

CONCLUSIONS
===========

Individual siRNAs can produce substantial off-target changes in mRNA abundance as a result of cross-hybridization between the seed region of the siRNA and the 3′UTR of the off-targeted transcript.Other cross-hybridization independent mechanisms might explain the increases in off-target mRNA abundance but are incompletely understood and therefore cannot necessarily be avoided by adding a feature to siRNA design algorithms.Complex d-siRNA pools are essentially free of off-target effects even when the diced pool is known to contain a problematic siRNA.The minimal off-target effects of d-siRNAs make them a particularly attractive method for large scale, loss-of-function screening experiments.

Supplementary Table 1.. Sequences of cloned siRNAs {#SD1}
==================================================

  Nucleotide Position   Sequence                 Times isolated
  --------------------- ------------------------ ----------------
  828                   GTTGTTGCAGGAGACCATGT     1
  853                   ACTGTCTCCATTATTGATCGG    1
  865                   ATTGATCGGTTCATGCAGA      1
  868                   GATCGGTTCATGCAG          1
  887                   ATTGTGTGCCCAAGAAGATGC    1
  893                   TGCCCAAGAAGATGCTGCAGCT   1
  897                   CAAGAAGATGCTGCAGCTGGTT   1
  906                   GCTGCAGCTGGTTGGT         3
  909                   GCAGCTGGTTGGTGTCACT      1
  916                   GTTGGTGTCACTGCCATGTTT    1
  953                   AAGAAATGTACCCTCCA        1
  981                   CTTTGCTTTTGTGACTGACAA    1
  982                   TTTGCTCTTGTGACTGACAACA   1
  986                   CTTTTGTGACT              1
  1028                  AGATGGAAATGAAGGTTCTAA    1
  1048                  AGAGCTCTAAACTTTGGTCT     1
  1058                  ACTTTGGTCTGGGTCGGCC      1
  1061                  TTGGTCTGGGTCGGCCTCTAC    2
  1066                  CTGGGTCGGCCTCTACCTTTG    2
  1067                  TGGGTCGGCCTCTACCTTTGC    1
  1074                  GCCTCTACCTTTGCACTTCCT    1
  1103                  CATCTAAGATTGGAGAGGTTG    1
  1105                  TCTAAGATTGGAGAGGTTGA     1
  1105                  TCTAAGATTGGAGAGGTTGATG   1
  1114                  GGAGAGGTTGATGTCGAGC      1
  1145                  CCAAATACCTGATGGAA        1
  1152                  CCTGATGGAACTAACTATG      1
  1169                  TGTTGGACTATGACATGGTGC    1
  1176                  CTATGACATGGTGCACTTTCC    1
  1185                  GGTGCACTTTCCTCCTTCTCA    1
  1190                  ACTTTCCTCCTTCTCAAATTG    2
  1192                  TTTCCTCCTTCTCAAATTGCAG   1
  1194                  TCCTCCTTCTCAAATTGCAGCA   1
  1195                  CCTCCTTCTCAAATTGCAGCA    2
  1197                  TCCTTCTCAAATTGCAGCAGG    1
  1198                  CCTTCTCAAATTGCAGCAGG     1
  1198                  CCTTCTCAAATTGCAGCAGGA    1
  1210                  GCAGCAGGAGCTTTTTGCTTA    1
  1219                  GCTTTTTGCTTAGCACT        1
  1220                  CTTTTTGCTTAGCACTGAAAA    1
  1256                  AATGGACACCAACTCTACAAC    1
  1300                  TCTCTTCTTCCAGTTATGCAG    1
  1335                  TGTAGTCATGGTAAATCAAGGA   1
  1342                  ATGGTAAATCAAGGA          1
  1390                  GCCACATNGAAGCATGC        1
  1398                  GAAGCATGCTAAGATCAGC      2
  1413                  CAGCACTCTACCACAGCTGA     1
  1447                  CAAGATTTAGCCAAGGCTGTGG   1
  1448                  AAGATTTAGCCAAGGCTGTGG    3
  1456                  GCCAAGGCTGTGGCAAAGGTG    1
  1458                  CAAGGGTGTGGCAAAG         1

Nucloetide position is relative to start codon as defined by human cyclin B1 sequence (NM 031966).

Supplementary Figure 1.. Comparison of off-target effects to previous data. mRNAs whose abundance decreased and had a match in their 3′-UTR to the seed region of a particular siRNA were selected from our data and previous data and are represented in the form of a heat map ([@B25]). {#SD2}
==========================================================================================================================================================================================================================================================================================
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